As Th17 cells are key participants involved in MS development, we enriched IL-17+ Th17 cells and found Th17 cells from MS patients expressed more IL-17 and TLR4 than those from healthy controls (Fig. 1a’). Here, TLR4 is linked to myeloid sarcoma.